The provided context does not include the full earnings transcript for Johnson & Johnson, which prevents a comprehensive analysis. However, based on these partial details:

Johnson & Johnson's Q4 earnings call addressed resiliency in a robust economic environment with perhaps a missing section but assuming key strategic updates, J& J appears focused on:
1. **Expanding Global Footprint**: Investing in and expanding operations internationally. 
2. **R&D Commitments:** Citing $12B in R&D spending, while details of specific outcomes are absent. 

Without full transcript or financial results: Speculative International investment implies short-term focus but resiliency means potential for positive hints toward future growth opportunities dependent on:
This partial information leaves inferences open and ratings are not final without key details. Hypothetically:

Given the usual resilience and strategic:
[-1]